Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V377I substitution and the low-penetrance TNFRSF1A R92Q mutation

被引:15
作者
Hoffmann, F
Lohse, P
Stojanov, S
Shin, YS
Renner, ED
Kéry, A
Zellerer, S
Belohradsky, BH
机构
[1] Univ Munich, Childrens Hosp, Dept Immunol & Infect Dis, D-80337 Munich, Germany
[2] Univ Munich, Dept Clin Chem Grosshadern, D-80539 Munich, Germany
[3] Univ Munich, Childrens Hosp, Dept Metab Dis, D-80337 Munich, Germany
关键词
hereditary periodic fever syndromes; hyperimmunoglobulinemia D and periodic fever syndrome; HIDS; tumor necrosis factor receptor-associated periodic syndrome; TRAPS;
D O I
10.1038/sj.ejhg.5201352
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) is an autosomal recessively inherited autoinflammatory disease caused by mutations in the mevalonate kinase (MVK) gene on chromosome 12q24, which lead to a depressed enzymatic activity of mevalonate kinase (MK). TNF-receptor associated periodic syndrome ( TRAPS), on the other hand, is the most frequent autosomal dominantly inherited periodic fever syndrome due to mutations in exons 2 - 4 and 6 of the TNFRSF1A gene on chromosome 12p13.2. We describe a girl with heterozygosity for the common MVK V377I mutation and for a novel T-1132 --> C transition, leading to the exchange of serine (TCC) by proline (CCC) at amino-acid position 378. Interestingly, our patient presented only with mild clinical features typical of HIDS and slightly increased immunoglobulin D levels, but a distinctly diminished MK activity. The girl was also heterozygous for the TNFRSF1A R92Q low-penetrance mutation, which may have significant proinflammatory effects. However, at the time of presentation, the patient had no TRAPS-associated symptoms.
引用
收藏
页码:510 / 512
页数:3
相关论文
共 16 条
[1]   Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis [J].
Aganna, E ;
Hawkins, PN ;
Ozen, S ;
Pettersson, T ;
Bybee, A ;
McKee, S ;
Lachmann, H ;
Karenko, L ;
Ranki, A ;
Bakkaloglu, A ;
Besbas, N ;
Topaloglu, R ;
Hoffman, H ;
Hitman, G ;
Woo, P ;
McDermott, M .
GENES AND IMMUNITY, 2004, 5 (04) :289-293
[2]   Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes [J].
Aganna, E ;
Hammond, L ;
Hawkins, PN ;
Aldea, A ;
McKee, SA ;
van Amstel, HKP ;
Mischung, C ;
Kusuhara, K ;
Saulsbury, FT ;
Lachmann, HJ ;
Bybee, A ;
McDermott, EM ;
La Regina, M ;
Arostegui, JI ;
Campistol, JM ;
Worthington, S ;
High, KP ;
Molloy, MG ;
Baker, N ;
Bidwell, JL ;
Castañer, JL ;
Whiteford, ML ;
Janssens-Korpola, PL ;
Manna, R ;
Powell, RJ ;
Woo, P ;
Solis, P ;
Minden, K ;
Frenkel, J ;
Yagüe, J ;
Mirakian, RM ;
Hitman, GA ;
McDermott, MF .
ARTHRITIS AND RHEUMATISM, 2003, 48 (09) :2632-2644
[3]   Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Dutch family:: evidence for a TNFRSF1A mutation with reduced penetrance [J].
Aganna, E ;
Aksentijevich, I ;
Hitman, GA ;
Kastner, DL ;
Hoepelman, AIM ;
Posma, FD ;
Zweers, EJK ;
McDermott, MF .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2001, 9 (01) :63-66
[4]   The tumor-necrosis-factor receptor-associated periodic syndrome:: New mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers [J].
Aksentijevich, I ;
Galon, J ;
Soares, M ;
Mansfield, E ;
Hull, K ;
Oh, HH ;
Goldbach-Mansky, R ;
Dean, J ;
Athreya, B ;
Reginato, AJ ;
Henrickson, M ;
Pons-Estel, B ;
O'Shea, JJ ;
Kastner, DL .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (02) :301-314
[5]   Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept [J].
Arkwright, PD ;
McDermottt, MF ;
Houten, SM ;
Frenkel, J ;
Waterhan, HR ;
Aganna, E ;
Hammond, LJ ;
Mirakian, RM ;
Tomlin, P ;
Vijaydurai, PI ;
Cant, AJ .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 130 (03) :484-488
[6]   Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome [J].
Cuisset, L ;
Drenth, JP ;
Simon, A ;
Vincent, MF ;
Visser, SV ;
van der Meer, JWM ;
Grateau, G ;
Delpech, M .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2001, 9 (04) :260-266
[7]   INFEVERS:: the Registry for FMF and hereditary inflammatory disorders mutations [J].
de Menthière, CS ;
Terrière, S ;
Pugnère, D ;
Ruiz, M ;
Demaille, J ;
Touitou, I .
NUCLEIC ACIDS RESEARCH, 2003, 31 (01) :282-285
[8]   HYPERIMMUNOGLOBULINEMIA-D AND PERIODIC FEVER SYNDROME - THE CLINICAL SPECTRUM IN A SERIES OF 50 PATIENTS [J].
DRENTH, JPH ;
HAAGSMA, CJ ;
VANDERMEER, JWM ;
WEEMAES, CMR ;
BIJLSMA, JWJ ;
DEGRAEFFMEEDER, ER ;
ALCALAY, M ;
CHAPELONABRIC, C ;
KAHN, MF ;
PRIEUR, AM ;
SIBILIA, J ;
POWELL, RJ ;
TOPALOGLU, R ;
SAATCI, U ;
SCOLOZZI, R ;
LAZZARIN, P ;
MONCIOTTI, CM ;
DEMONTY, J ;
JILEK, D ;
MIYAGAWA, S ;
ESPANOL, T .
MEDICINE, 1994, 73 (03) :133-144
[9]   Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome [J].
Drenth, JPH ;
Cuisset, L ;
Grateau, G ;
Vasseur, C ;
van de Velde-Visser, SD ;
de Jong, JGN ;
Beckmann, JS ;
van der Meer, JWM ;
Delpech, M .
NATURE GENETICS, 1999, 22 (02) :178-181
[10]   Medical progress: Hereditary periodic fever. [J].
Drenth, JPH ;
van der Meer, JWM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (24) :1748-1757